Matthew R. Rowe

MiR-449a promotes breast cancer progression by targeting CRIP2

Wei Shi, Jeff Bruce, Matthew Lee et al. · Oncotarget · 2016 · 56 citations · Full text

Medicine, Molecular Biology, Oncology +17

Mitochondrial transfer between cells: Methodological constraints in cell culture and animal models

Michael V. Berridge, Patries M. Herst, Matthew R. Rowe et al. · Analytical Biochemistry · 2017 · 36 citations

Life Sciences, Biology, Cell Biology +11

The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy

Marie-Sophie Fabre, Nicole M. Stanton, Tania L. Slatter et al. · PLoS ONE · 2020 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +17

βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug–tubulin interactions and microtubule stability

Arun Kanakkanthara, Matthew R. Rowe, Jessica J. Field et al. · Cancer Letters · 2015 · 19 citations

Medicine, Molecular Biology, Pharmacology +17

Targeted inhibition of dominant PI3-kinase catalytic isoforms increase expression of stem cell genes in glioblastoma cancer stem cell models

Nicole Jones, Matthew R. Rowe, Peter R. Shepherd et al. · International Journal of Oncology · 2016 · 18 citations · Full text

Medicine, Cell Biology, Oncology +17